Literature summary extracted from
Gyemant, G.; Zajacz, A.; Becsi, B.; Ragunath, C.; Ramasubbu, N.; Erdodi, F.; Batta, G.; Kandra, L.
Evidence for pentagalloyl glucose binding to human salivary alpha-amylase through aromatic amino acid residues (2009), Biochim. Biophys. Acta, 1794, 291-296.
Cloned(Commentary)
| EC Number |
Cloned (Comment) |
Organism |
|---|
| 3.2.1.1 |
expression and purification carried out using a Bac-To-Bac Baculovirus Expression System |
Homo sapiens |
Protein Variants
| EC Number |
Protein Variants |
Comment |
Organism |
|---|
| 3.2.1.1 |
W58L |
reduced inhibitory efficiency of the mutants W58L and Y151M with 92 and 97% remaining enzyme activity at 0.00235 mM pentagalloyl glucose inhibitor concentration, respectively, pH 6.0, 37°C |
Homo sapiens |
| 3.2.1.1 |
Y151M |
reduced inhibitory efficiency of the mutants W58L and Y151M with 92 and 97% remaining enzyme activity at 0.00235 mM pentagalloyl glucose inhibitor concentration, respectively, pH 6.0, 37°C |
Homo sapiens |
Inhibitors
| EC Number |
Inhibitors |
Comment |
Organism |
Structure |
|---|
| 3.2.1.1 |
1,2,3,4,6-pentagalloyl-beta-D-glucose |
mixed non-competitive inhibition, KEI: 0.0026 mM, KEIS: 0.0039 mM, tested in a concentration range of 0.04 to 0.5 mM, reduced inhibitory efficiency of the mutants W58L and Y151M with 92 and 97% remaining enzyme activity at 0.00235 mM inhibitor concentration, respectively, pH 6.0, 37°C |
Homo sapiens |
|
Organism
| EC Number |
Organism |
UniProt |
Comment |
Textmining |
|---|
| 3.2.1.1 |
Homo sapiens |
- |
- |
- |
Purification (Commentary)
| EC Number |
Purification (Comment) |
Organism |
|---|
| 3.2.1.1 |
recombinant protein, expression and purification carried out using a Bac-To-Bac Baculovirus Expression System |
Homo sapiens |
Source Tissue
| EC Number |
Source Tissue |
Comment |
Organism |
Textmining |
|---|
| 3.2.1.1 |
saliva |
type IXA |
Homo sapiens |
- |
Substrates and Products (Substrate)
| EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
|---|
| 3.2.1.1 |
2-chloro-4-nitrophenyl alpha-D-galactopyranosyl-(1-4)-alpha-D-galactopyranosyl-(1-4)-alpha-D-galactopyranoside + H2O |
- |
Homo sapiens |
2-chloro-4-nitrophenol + alpha-D-galactopyranosyl-(1-4)-alpha-D-galactopyranosyl-(1-4)-alpha-D-galactopyranose |
the increase of absorbance of 2-chloro-4-nitrophenol liberated by HSA is measured continuously at 400 nm |
? |
|
Synonyms
| EC Number |
Synonyms |
Comment |
Organism |
|---|
| 3.2.1.1 |
HAS |
human salivary alpha-amylase |
Homo sapiens |
| 3.2.1.1 |
human salivary alpha-amylase |
commercial preparation |
Homo sapiens |
Temperature Optimum [°C]
| EC Number |
Temperature Optimum [°C] |
Temperature Optimum Maximum [°C] |
Comment |
Organism |
|---|
| 3.2.1.1 |
6 |
- |
assay at |
Homo sapiens |
pH Optimum
| EC Number |
pH Optimum Minimum |
pH Optimum Maximum |
Comment |
Organism |
|---|
| 3.2.1.1 |
6 |
- |
assay at |
Homo sapiens |
Ki Value [mM]
| EC Number |
Ki Value [mM] |
Ki Value maximum [mM] |
Inhibitor |
Comment |
Organism |
Structure |
|---|
| 3.2.1.1 |
0.00235 |
- |
1,2,3,4,6-pentagalloyl-beta-D-glucose |
pH 6.0, 37°C, the mutants Y151M and W58L exhibit reduced inhibitory efficiency with 92 and 97% remaining enzyme activity at 0.00235 mM inhibitor concentration, respectively, pH 6.0, 37°C |
Homo sapiens |
|